GP404141 + Nplate
Phase 3Active 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Drug Effect
Conditions
Drug Effect, Safety Issues, Immunogenicity
Trial Timeline
Apr 4, 2023 → Mar 31, 2028
NCT ID
NCT06497036About GP404141 + Nplate
GP404141 + Nplate is a phase 3 stage product being developed by GEROPHARM for Drug Effect. The current trial status is active. This product is registered under clinical trial identifier NCT06497036. Target conditions include Drug Effect, Safety Issues, Immunogenicity.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06497036 | Phase 3 | Active |
Competing Products
20 competing products in Drug Effect